Medical device based companies are now unleashing latest products for diabetes treatment which promise an improvement in the quality of lifestyle for patients. This also aids the manufacturers with a potential position in the ever-growing drug market.
Tandem Diabetes (TNDM) and Abbott Laboratories (ABT) are among the ones jockeying for a section of the market for diabetes treatment that would be worth much more than $2 Trillion as we reach the year 2030.
These medical devices serve as a boon for the insulin-dependent patients which is a group estimated to be as high as 3.3 Billion in the United States as confirmed by Joanne Wuensch, the analyst from BMO Capital Markets. In her statement, Wuensch mentioned that currently, the market is at its most unique time frame where the companies, technologies, as well as the FDA, are all proceeding in the very same direction.
One among the patients who benefitted from this was Ambar Chacoma, who is a 12-year-old Glendale resident at California. Ambar was actually diagnosed with the Type 1 diabetes back when he was 9 years old. Managing his diabetic state was actually a dangerous nightmare, as stated by Carlos Chacoma, his father to the Investor’s Business Daily. Ambar’s blood sugar was monitored by his parents every now and then to ensure that everything is fine. The couple took turns to check-in on Ambar starting at 1 a.m., followed by 3 a.m., 5 a.m., and lastly 7 a.m.
His father also mentioned that Ambar was completely dependent on the needles and shots for more than a year after which they decided to start the use of a Medtronic device. With its help, they do not have to look through shifts for monitoring his blood sugar level. The device has been designed to automatically measure the blood sugar and accordingly deliver the insulin if required.
Before this machine, Ambar had a hard time going out or playing with friends. Either one of the parents had to accompany her. They couldn’t let anyone else keep an eye on her given the fact that no one was trained enough to monitor Ambar in a way they could. Now, she can easily go on field trips with school friends and teachers without the need of her parents to accompany her.
Modern glucose monitors and insulin pumps have changed the way diabetes treatment was perceived earlier. Today, everything is available readily and having these devices to help out makes life easier.